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A  variety of treatments  at the time of transplantation  may induce rodents to 
accept major histocompatibility complex-incompatible organ allografts without 
further immunosuppression  (1-7).  Passively administered  anti-donor strain hy- 
perimmune  globulin, active immunization  with donor strain blood or lymphoid 
cells (1,2), or short courses of either cyclosporine (CY) 1 (4, 5), or antilymphocyte 
globulin can all  lead to indefinite graft survival in rats (6, 7).  Following each of 
these  treatments,  a  proportion  of rats  develop  a  state  in  which  the  immune 
system is incapable of mounting a rejection response against donor strain organ 
allografts, but retains the capacity to reject third-party allografts (1, 5, 8).  In all 
cases,  the  state  of unresponsiveness  is  not  established  for  at  least  7  wk  after 
transplantation,  and becomes progressively more marked with time, to the extent 
that  a  large  proportion  of the  rats  in  which  organ  graft  survival  has  been 
prolonged by one of the above measures will eventually accept donor strain skin 
grafts  (1,  5,  8).  Although  humoral  responses  play  an  important  role  in  the 
induction  of many of these  forms of unresponsiveness,  their  role in  long-term 
maintenance of unresponsiveness has never been conclusively established (9-11). 
On the other hand,  several groups have shown (8,  11-16) that unresponsiveness 
is actively mediated by host lymphoid cells, and that  T  cells contribute to this 
inhibitory response. 
It  is  now  recognized  that  there  are  several  effector  mechanisms  with  the 
potential to mediate graft rejection. Adoptive transfer experiments have demon- 
stated that both helper/inducer  and cytotoxic/suppressor subsets of T  cells can 
restore the capacity of immunosuppressed hosts to effect rejection (17-20).  As 
far as cell populations from unsensitized animals are concerned, it is evident that 
the  helper/inducer  T  cell  subset  restores  rejection  to  irradiated  hosts  when 
injected  either  alone  or  with  cytotoxic  cells.  When  injected  alone,  however, 
neither the cytotoxic T  cell subset nor B cells have the capacity to effect rejection 
(18,  20).  Adoptive transfer  systems have also been  used to establish  that  cells 
from  rats  with  long-surviving  grafts  do  not  restore  rejection  of donor  strain 
1  Abbreviations used in this paper:  CY, cyclosporine; LNC, lymph node cell; W/F, Wistar-Furth. 
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hearts  in  adoptive  hosts,  and  furthermore,  at  least  in  the  case  of cells  from 
enhanced  or  CY-treated  donors,  can  inhibit  the  capacity  of  simultaneously 
transferred normal lymphocytes to do so (12-14,  16). 
In this study,  we examined  the capacity of separated populations  of helper/in- 
ducer  or  cytotoxic/suppressor  subclasses  of T  cells  and  of  B  cells  from  CY- 
treated  DA rats with  long-surviving PVG heart  grafts either to effect rejection 
or to transfer unresponsiveness in the adoptive allograft assay. 
Materials and  Methods 
Rats.  Rats of the  DA (RTI"), PVG (RTI~), and  Wistar-Furth  (W/F)  (RTlU) strains 
were bred  in  the  Blackburn  Animal  House,  and  maintained  in  the  Pathology Animal 
House at the University of Sydney. 
Operative Procedures.  DA rats, anesthetized with ether, were grafted with PVG or W/F 
hearts by end-to-side anastomosis of the ascending aorta to the abdominal aorta and the 
pulmonary artery to the  inferior vena cava, as described  elsewhere (21).  Donors  were 
150-200-g female rats, and recipients were 250-300-g male rats. 
Graft ischemia times ranged from 25-40 min, and all grafts commenced to contract 
within 2 min of the restoration of blood supply. Graft function was monitored daily, and 
rejection  was  determined  by  loss  of palpable  contraction  and  confirmed  by  loss  of 
electrocardiogram activity. On the day electrocardiogram activity was lost, an autopsy was 
performed and graft tissue was obtained for histological confirmation of rejection. 
Cell Preparations.  Single-cell suspensions from spleen  and  lymph node cells (LNC), 
were prepared as described elsewhere (22). Subpopulations of lymphocytes were identified 
by the  mouse  monoclonal antibodies  W3/13  (pan-T),  W3/25  (T helper/inducer),  and 
MRC OX8 (T cytotoxic/suppressor) (Sera Laboratories, Oxford, United Kingdom), using 
an indirect immunofluorescence technique described elsewhere (18).  Ig  ÷ cells were iden- 
tified,  using fluorescein isothiocyanate-labeled rabbit anti-rat  Ig (DAKO, Copenhagen, 
Denmark) (22). 
Cell Separation.  Full  details  of the  cell  separation  techniques  have previously been 
described (l 8). Ig  + cells were removed from whole lymphocyte populations by incubation 
of the cell preparation on plastic petri dishes (Lab Tek; Miles Laboratories, Inc., Naper- 
ville, IL) coated with  rabbit anti-rat  Ig (DAKO).  The resultant cell preparations were 
99% W3/13 + and <1% Ig÷; 70-80% of the W3/13 + cells in the original preparation were 
recovered. 
T  cell  subpopulations were separated by binding either MRC OX8 or W3/25  to the 
cells before panning on plates coated with both rabbit anti-mouse Ig (DAKO) and rabbit 
anti-rat  Ig. The nonadherent  population  from MRC  OX8-bound cell populations was 
95-97%  W3/25 +,  1-2%  Ig  ÷,  and  1-2%  MRC  OX8 ÷,  that  from  W3/25-bound  cell 
populations was 90-95% MRC OX8 ÷, 2-5 % Ig  +, and  1-5% W3/25 +. 
B ceils were prepared by binding W3/13 to cells before panning on plates coated with 
rabbit anti-mouse Ig that had been blocked for anti-rat Ig activity by preincubation with 
normal DA rat serum. Nonadherent populations were 90-98% Ig  + and 5-10% W3/13 ÷. 
Treatment of Rats to Induce Long-term Graft Survival.  DA rats were grafted with PVG 
hearts and  given  CY  (a  gift of Sandoz,  Ltd.,  North  Ryde,  Australia) at  a  dose  of 10 
mg/kg  body  weight/day.  CY,  supplied  as  a  powder,  was  diluted  in  olive  oil,  mixed 
overnight with a magnetic stirrer, then stored at 4°C. The appropriate dose was pipetted 
into the pharynx of lightly anesthetized animals. Grafted rats were given CY immediately 
postoperatively, and then once daily for 10 d. Grafts in treated animals survived for >100 
d, compared to a survival time of 6-7 d in untreated controls. Cells from rats with PVG 
grafts surviving longer than 75 d were used in these studies. 
Experimental Design.  Donor and recipient rats for adoptive transfer experiments were 
irradiated  from a  " Co source at  150  rad/min  to a  total dose of 900  rad as described 
before (22), and within 24 h, the DA recipients were grafted with hearts from PVG or 
W/F donors.  Irradiated DA recipients given no cells do not reject PVG or W/F hearts HALL  ET  AL.  1685 
for at least 50 d, and many retain their grafts indefinitely (>150 d). The capacity to reject 
a heart graft from either strain can be restored to irradiated recipients by the adoptive 
transfer of normal syngeneic LNC or spleen cells.  Animals restored with equal numbers 
of normal cells reject PVG and W/F hearts with a similar tempo. Rejection of heart grafts 
after adoptive transfer of 1.5  ×  108  LNC occurs at 9.3  +  0.6 d  for five subjects given 
PVG hearts, and at 9.7 ___ 0.9 in five other rats given W/F hearts; after 3 X 10 v LNC were 
transferred, rejection occurred at  15.2 +  3.9 d (five rats), and at 17.0 +  4.6 d (six rats) 
for PVG and W/F transplants, respectively. As normal cells display equal reactivity toward 
PVG and W/F grafts, this assay is ideal for the detection of a specific loss of alloreactivity 
in a given cell population. In addition, because the relationship between the number of 
cells used to restore rejection and the rejection time is quantitative, the assay reflects the 
extent of the loss of alloreactivity in a cell population. 
Statistics.  Differences in rejection time between groups of rats restored with equivalent 
inocula were analyzed using the Wilcoxon rank sum test. A p value of<0.05 was considered 
to reflect a significant difference. 
Results 
The  starting  point  for these experiments  was the  observation that  LNC and 
spleen cells,  or their  T  cell fraction,  from CY-treated  DA rats with PVG heart 
grafts  that  had  been  accepted  for  >75  d  failed  to  restore  PVG  heart  graft 
rejection,  but effected third-party  (W/F)  rejection  when adoptively transferred 
to  irradiated  DA  rats  (Table  I).  In the  few recipients  in  which  cells from CY- 
treated rats did effect rejection, it was with a  slower tempo than in control rats 
given an equivalent number of normal DA cells. The time course of rejection of 
W/F grafts in animals restored with cells from CY-treated rats with PVG grafts 
was not impaired, nor was it different from that achieved with normal cells. 
When cells from DA rats with long-surviving grafts were mixed with normal 
LNC and  adoptively transferred  to  irradiated  grafted  recipients,  it was clearly 
shown  that  the  former  cell  population  did  not  merely  lack  reactivity  towards 
TABLE  I 
Survival of PVG and W/F Hearts in Irradiated DA Rats Restored with Cells from CY-treated Rats 
with Long-Surviving PVG AUografts 
Restorative inocula  Rejection time 
CY-treated DA LNC and 
PVG hearts  W/F hearts 
Normal DA  spleen cells* 
Animals surviving on days  Animals surviving on days  Median  LNC  Number of  Fraction  Median  p~  p! 
cells  (N~  (N)  t 
108  --  --  8, 9, 13 (3)  13  8, 10, I I, 13  i0.5  NSD 
<0.005 
i  1.5 x  l0  s  Whole  25, 26, >100 (6)  >100  12, 14, 15,21  14.5  <0.0l 
NSD 
3  x  107  1.5 ×  10  a  Whole  20, 24, 26, >100 (5)  >100  13, 14, 15, 23  14.5  <0.01 
<0.02 
3x107  --  --  13 (3), 15, 22, 28  15  14 (2), 15 (2), 18, 26  15  NSD 
<0,05 
3  x  107  7.5 ×  107  T  cells  10, 19,>100 (3)  >100  NT 
NSD 
--  7.5 ×  10  ~'  T  cells  >100 (7)  >100  NT 
NSD 
--  --  --  40, 53, 68, >100 (5)  >100  :-100 (4)  :-100  NSD 
*  DA rats, previously treated with CY with PVG grafts surviving >75 d. 
:~ Numbers in parentheses are numbers of individuals surviving to that day. NT, not tested. 
! Significance determined by Wilcoxon  rank sum test. NSD, not significantly different. 1686  MEDIATION  OF  ALLOSUPPRESSION  BY  T  HELPER  CELLS 
specific antigen,  but  had  the  capacity,  specifically,  to  inhibit  the  reactivity of 
normal cell populations (Table I). The identity of the inhibitory cell was sought 
in  experiments  in  which  lymphocyte subsets  were  separately assayed for their 
capacity to suppress normal cells. 
Role  of Helper/Inducer  (W3/25 +) Cells in  Adoptive  Transfer  of Unresponsive- 
ness.  In a  large number of adoptive transfer experiments, the W3/25 + cell has 
been shown to be the principal cell required for the restoration of graft rejection 
in T  cell-depleted animals. Graft rejection can be adoptively restored with small 
numbers of W3/25 + cells, whereas even large numbers of MRC OX8 + cells from 
normal DA rats do not effect rejection (Table I1). In fact, as few as 106 W3/25 + 
cells  can  restore  rejection  in  <20  d,  and  are  as  effective as  20  times  more 
W3/25 + cells.  These studies suggest that only a  very few alloreactive W3/25 + 
cells are  required  to  initiate  the  rejection  response  in  the  irradiated adoptive 
host.  Tests of large numbers of W3/25 + cells from CY-treated  rats with long- 
surviving grafts all failed to restore rejection. 
Unfractionated  LN  and  spleen  cells  contain  40%  W3/25 + cells,  therefore, 
inocula of 6  ×  107  W3/25 +, which represents  the number present in  1.5 ×  108 
unfractionated cells, were used in experiments to test the role of W3/25 + cells 
in the adoptive transfer of unresponsiveness. 6 ×  107 W3/25 + cells from normal 
DA donors restored both PVG and W/F rejection to the tempo achieved with 
1.5  ×  10 ~ whole  LNC.  In  contrast,  6  ×  10 v W3/25 + cells from  DA  rats  with 
long-surviving  grafts  effected  rejection  of PVG  grafts  in  only  two  of eight 
adoptive hosts, but effected rejection of all W/F grafts with a  tempo similar to 
that achieved by the same number of normal W3/25 + cells (Table III). Thus, an 
innoculum of W3/25 + cells from rats  with  long-surviving grafts, with over  20 
TABLE  II 
Survival of PVG Grafts in Irradiated DA Rats after Adoptive Restoration with W3/25 + or 
MRC OX8 ÷ Cells Separated from Normal DA LNC 
Restorative inocula  Rejection time 
Number of 
Number of  Subset  Day*  Median  p§  LNC-equiva-  cells 
lents* 
2  ×  108  7.5 ×  107  W3/25 +  10,  12,  14 (2), 20, 24  14 
NSD 
5  x  107  2  x  107  W3/25 +  14 (2),  15 (2),  18, 20  15 
NSD 
107  5  ×  106  W3/25 +  11  (2),  12 (5),  14, 33  12 
NSD 
2.5 x  106  106  W3/25 +  7, 9,  13,  14,  18, 27  13.5 
<0.05 
2  ×  108  3.3 ×  107  MRC OX8 +  >100 (4)  >100 
NSD 
5  x  l07  7  ×  106  MRC OX8 +  90, >100 (5)  >100 
* Doses of T  cell subsets were given in numbers equivalent to that found in an inoculum of whole 
LNC, on the basis that 37-43% are W3/25" and  12-17%  MRC OX8 +. 
* Numbers in parentheses are numbers of individuals. 
Significance determined by Wilcoxon rank sum test. NSD, not significantly different. HALL  ET  AL.  1687 
TABLE III 
Survival of PVG and W/F Heart Grafts in Irradiated DA Rats Restored with W3/25  + Cells 
from Either Normal or CY-treated DA Rats with Long-surviving  PVG Grafts 
Restorative inocula  Rejection time 
Source of  3 x  107 nor-  PVG hearts  W/F hearts 
W3/25 + cells  mal LNC 
(6 x  107 cells  Animals surviv-  p,  Animals surviv-  p, 
used)  added  ing on day (N)*  Median  ing on day (N)*  Median 
Normal  -  10,  12,  14 (2),  14  10,  11  (2),  J 1 
DA  20, 24  <0.01  15, 20 
CY Rx  -  18, 29, >100  >100  13,  15,  17  17 
DA  ~  (8)  NSD  (2),  18, 23 
CY Rx  +  8,  12 (2), 40,  >40  NT 
DA  §  >100 (4)  <0.05 
--  +  11  (4),  15,  18  11  NT 
NSD 
* Numbers in parentheses are numbers of individuals. NT, not tested. 
* Significance determined by Wilcoxon rank sum test. NSD, not significantly different. 
DA rats previously treated with CY and bearing long-surviving PVG grafts. 
times the number of cells required to restore rejection, showed a marked specific 
loss of alloreactivity. 
We next examined whether the apparently unreactive W3/25 + cell population 
could actively inhibit the alloreactivity of normal cells.  6  x  107  W3/25 + cells 
from DA rats with long-surviving grafts were mixed with 3  x  107  normal LNC 
and adoptively transferred to irradiated DA rats with PVG heart grafts (Table 
III). Three of eight rats rejected their grafts within  12  d, one rat rejected its 
graft in 40 d, and four retained their grafts indefinitely (Table III). Control rats 
given  3  x  107  normal LNC alone all rejected their grafts within  18  d.  These 
results suggest that,  in  the experZnental group,  the added W3/25 + cells  had 
inhibited the allograft responsiveness of the normal cells. 
Because normal LNC contain both helper/inducer and cytotoxic T  cells,  and 
B cells,  it is possible that the W3/25 + cells from the DA rats with long-surviving 
grafts had stimulated either the B cells or the cytotoxic/suppressor cells  in the 
admixed normal population, and that these had in turn mediated an inhibitory 
response. Therefore, experiments were done in which W3/25 + cells  from rats 
with long-surviving grafts were adoptively transferred with only the W3/25 + cell 
population separated from normal LNC (Table IV). Four of five irradiated DA 
hosts given 4 x  10 ~ W3/25 + cells from rats with long-surviving grafts and normal 
5  X  106  W3/25 + cells  did  not  reject  their  grafts.  2  x  107  W3/25 ÷ cells  also 
impaired the restorative capacity of 5 x  106 normal W3/25 + cells. This suggests 
that the inhibitory effect is mediated by the W3/25 + cells themselves, and is not 
a consequence of the induction of an inhibitory response mediated by other cell 
populations in the adoptively transferred normal LNC population. 
Role of  MRC OX8 + Cells in Adoptive Transfer of Unresponsiveness.  It has already 
been well established by others (17) and by us (Table II), that the cytotoxic/sup- 
pressor  MRC  OX8 + population  from  normal  rats  does  not  restore  the  graft 
rejection response to irradiated hosts, thus MRC OX8 + cells  from CY-treated 
rats were tested only for their inhibitory capacity. 2 ×  107 MRC OX8 + cells from 
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TABLE  IV 
Survival of PVG Hearts in Irradiated DA Rats Restored with 
W3/25 + Cells from CY-treated DA Rats with Long-surviving PVG 
Heart Grafts and/or W3/25 ÷ Cells  from Normal DA rats 
J 
Restorative inocula; number 
of W3/25 + cells from  Rejection time 
cell donors 
Animals surviving  Median  p§  CY Rx DA  Normal DA  on day (N)* 
4 x  107  --  18, 29, >100 (6)  >100 
NSD 
4 x  107  5 x  106  12, >100 (4)  >100 
<0.1 
--  5  x  106  ll (2),  15, 33, 37  15 
<0.1 
2 x  107  5 x  106  >100 (3)  >100 
* DA rats  previously treated  with  CY and  bearing long-surviving PVG 
grafts. 
Numbers in parentheses are numbers of individuals. 
§ Significance determined by Wilcoxon rank sum test.  NSD, not signifi- 
cantly different. 
TABLE  V 
Survival of PVG Heart Grafts in Irradiated Rats Restored with MRC OX8 + Cells from 
Normal or CY-treated DA Rats with Long-Surviving PVG Grafts 
Restorative inocula 
MRC OX8 ÷  Normal LN  Normal 
cells (3 ×  W3/25 + cells 
(2 x  107 cells  107 cells  (5 x  106 
used)  used)  cells used) 
Rejection time 
Animals surviving on day (N)*  Median  p~ 
Normal DA  -  -  >100 (5)  >100 
<0.05 
CYRxDA ~  +  -  12,13(2),  14  13 
NSD 
--  +  -  12, 13 (2),  17 (2)  13 
Normal DA  -  +  7 (3), 9 (2)  7 
<0.01 
--  -  +  9,  11  (2),  12 (2),  13 (2),  14  12 
NSD 
CY Rx DA  ~  -  +  9 (2),  11,  14 (2), >100  12.5 
* Numbers in parentheses are numbers of individuals. 
* Significance determined by Wilcoxon rank sum test. NSD, not significantly different. 
§ DA rats previously treated with CY and bearing long-surviving PVG grafts. 
cells) did not inhibit  the capacity of 3  X  107  normal  DA  LNC  to effect rejection 
(Table  V).  MRC  OX8 + cells from  rats with long-surviving  grafts were also tested 
for  their  capacity  to  inhibit  the  restoration  of  graft  rejection  by  the  W3/25  + 
subset of normal  LNC.  It was found  that  2  X  107  MRC  OX8 + cells from  DA rats 
with  long-surviving  grafts did not  inhibit  the  ability of 5  x  106  normal  W3/25  + 
cells  to  restore  graft  rejection  (Table  V).  Thus,  these  experiments  revealed  a 
marked  difference  between  the  W3/25  + and  the  MRC  OX8 +  subsets  from  rats HALL  ET  AL.  1689 
with long-surviving heart grafts.  2 X  107 W3/25 + cells inhibited the restoration 
of graft rejection by 5 x  106 normal W3/25 + cells, but 2 x  107 MRC OX8 + cells 
did  not do so.  Although  2  x  107  OX8 ÷ cells from  normal  donors apparently 
increased the alloimmune capacity of normal W3/25 + cells (Table V), the same 
number of OX8 + cells from rats with long-surviving grafts did not do so. 
Role of B Cells and Sera in Adoptive Transfer of Unresponsiveness.  The possible 
role of B cells in the maintenance  of unresponsiveness was examined  using the 
adoptive transfer assay, by transfer of normal  LNC mixed with B cells or sera 
from rats with long-surviving grafts. Neither B cells, nor serum from normal DA 
rats  alone  restore  rejection  (18),  nor  do  they  alter  the  capacity  of  normal 
lymphocytes to do so in adoptive transfer assays (Table VI).  Thus,  B cells and 
sera from rats with  long-surviving  grafts were only tested for their capacity to 
inhibit  the  allograft  reactivity  of 3  ×  107  normal  DA  LNC.  Neither  did  so, 
suggesting that B cell activity does not maintain  unresponsiveness in CY-treated 
rats  (Table  VI).  We established  that  the  assay is  suitable  for the  detection  of 
antibody that  can  inhibit  the rejection  response,  by demonstrating  that  serum 
from an untreated DA rat, which had rejected a PVG graft, specifically inhibited 
the restorative capacity of normal LNC (Table VI). 
Discussion 
These  experiments  showed  that  rats  in  which  rejection  of fully  allogeneic 
cardiac allografts  has  been  prevented  by a  course of CY treatment  develop a 
state of specific unresponsiveness characterized  by an inability of the T  helper/in- 
ducer  cells  to  initiate  rejection.  More  significantly,  they  showed  that  the  T 
helper/inducer cells from these animals have the capacity to inhibit the initiation 
of the rejection response by normal  helper/inducer  cells.  Neither  cytotoxic/sup- 
pressor T  cells nor antibody appeared to contribute to the maintenance  of the 
state of CY-induced unresponsiveness. 
The failure of rats to reject their  grafts while receiving CY can be explained 
by the  drug's  capacity to  inhibit  T  cell  activation.  CY apparently  inhibits  the 
activation  and  proliferation  of helper/inducer  T  cells,  and  thus  prevents  the 
production  of interleukin  2  and  other  lymphokines,  which are  critical  for the 
activation of cytoxic T  cells and B cells (23-29). It does not appear to inhibit the 
activation  of suppressor T  cells (27,  29).  The  failure to effect rejection of the 
graft and the specific unresponsiveness that develops once CY is stopped cannot 
TABLE  VI 
Survival of PVG Grafts in Irradiated DA Rats Restored with 3 X  107 Normal LNC, and 
Given Either B Cells or Serum from CY-treated DA Rats with Long-surviving PVG Grafts 
Addition to restorative inoculum 
Dose  Source 
Rejection time 
Animals surviving on day (N)*  Median 
4 ×  ]07 B cells  CY Rx DA*  8,  12,  15,  16  13.5 
2 ml serum  CY Rx DA*  8 (2),  12 (2),  13 (3),  14,  15  12 
2 ml serum  Normal DA  13 (2),  14,  15 (2)  13.5 
2 ml serum  DA-rejected PVG  ~  >100 (4)  >100 
* Numbers in parentheses are numbers of individuals. 
* DA rats previously treated with CY and bearing long-surviving PVG grafts. 
§ From untreated DA rats that had rejected PVG grafts. 1690  MEDIATION  OF  AI.I_,OSUPPRESSION  BY  T  HELPER  CEI.LS 
be attributed to a direct effect of CY, however. The animals used in our studies 
had not received CY for at least 75 d, by which time CY is not detectable in any 
tissues. 
Nagao et al. (5), in a detailed study of the development of unresponsiveness in 
CY-treated heart-grafted rats, showed that the phase of specific unresponsiveness 
was not manifest until >50 d after cessation of CY treatment, and that the degree 
of unresponsiveness continued to increase with time. A similar pattern of devel- 
opment of specific unresponsiveness is seen in rats in which graft rejection has 
been inhibited  by passive or active enhancement  regimes,  prior  donor-specific 
blood transfusion, or treatment with antilymphocyte globulin (1-3, 6, 7). In each 
of these models, prolonged graft survival is due in part to the development of a 
state of specific unresponsiveness mediated by a  suppressor T  cell response (3, 
7,  13-16), and in part,  to reduced immunogenicity of the implanted graft (15, 
30).  We suggest that  the  mechanism  of unresponsiveness is similar  in  all  these 
models, and that in each case, the initial treatment acts by minimizing the helper/in- 
ducer T  cell response. 
The central role of T  helper/inducer cells in mediating rejection is highlighted 
by adoptive transfer experiments in which these cells are the only cells required 
to  restore  the  capacity  of either  heavily  irradiated  or  adult  thymectomized, 
irradiated, and bone marrow-reconstituted rodents to reject grafts (17-20). It is 
still  not clear whether the helper/inducer  T  cells themselves effect rejection, or 
whether they induce host-derived cytotoxic T  cells or B cells to do so (19, 20). 
Whatever the ultimate mediator is, it is clear that tissue destruction is dependent 
upon the alloactivation of helper/inducer  T  cells. It is possible that treatments, 
which initially inhibit the T  helper response to alloantigen,  either allow cells of 
this  subclass to  transform  into  antigen-specific  suppressor  cells,  or  permit  the 
generation of a  new population of W3/25 + cells with suppressor potential. The 
paradoxical finding that cells from rats with specific unresponsiveness associated 
with  long-surviving  allografts,  which  lack  the  capacity  to  initiate  a  rejection 
response either in the original  or adoptive host, have normal reactivity in graft 
vs.  host assays and  mixed  lymphocyte cultures  when  reexposed to  graft-strain 
alloantigens  remains  unexplained (1,  8).  It has been suggested (30) that  failure 
of these cells to effect rejection  in  the original  host is due to loss of dendritic 
cells  from  the  graft.  However, a  second new  graft,  not depleted of dendritic 
cells,  given  to  these  animals  also  fails  to  induce  a  rejection  response.  In  our 
model, the graft in the adoptive recipient is demonstrably sufficiently immuno- 
genic  to  stimulate  small  numbers  of normal  lymphoid cells to  effect rejection 
(18,  20,  22),  however,  cells  from  CY-treated  animals  do  not  reject  it.  These 
findings  confirm  that  a  mechanism  other than  loss of graft  immunogenicity  is 
implicated  in  the  long-term  survival  of organ  grafts  in  CY-treated  rats.  We 
suggest that the suppressor cells we have identified are the principal mechanism 
of unresponsiveness,  and that  graft adaptation  plays only a  minor role in  long- 
term survival. 
It was clear  fi'om our experiments  that  the  T  cells that  maintain  long term 
unresponsiveness do not belong to the classical cytotoxic/suppressor subpopula- 
tion. Suppression mediated by the helper/inducer T  cell has also been shown in 
graft-vs.-host disease (31),  tumor allograft models (32),  in vitro cytolytic T  cell HALL  ET  AL.  1691 
responses (33, 34), and delayed-type hypersensitivity responses to dinitrofluoro- 
benzene (35). 
Others (36, 37) have identified a suppressor cell response in heart-grafted rats 
treated with  CY.  The  suppressor cells characterized  by this  group were cyclo- 
phosphamide-sensitive,  had the capacity to inhibit lymphokine production, and, 
in contrast to the population identified by us, were apparently of the cytotoxic 
suppressor  subset;  partial  suppression  (but  not  indefinite  graft  survival)  was 
transferred to normal Lewis strain adoptive hosts with MRC OX8  + cells, but not 
with  W3/25 + cells.  There  is no ready explanation  for the  difference between 
these results (36, 37) and ours. However, recent studies (38) on the suppression 
of  antibody  responses  have  suggested  that  a  series  of  T  cells  of  different 
phenotypes may be involved in the induction  and  mediation  of suppression.  If 
this is also the case for the suppression of T-mediated responses, the differences 
between our findings and those previously published (36, 37) may be due to the 
identification of cells that mediate different parts of the suppressor circuit (38). 
Our results strongly suggest that  W3/25 + cells from grafted CY-treated rats 
have  the  capacity to  directly  suppress normal  W3/25 + cells.  It  was clear  that 
neither adoptively transferred normal  MRC OX8 ÷ cells nor B cells are essential 
for the induction  of suppression  in  irradiated  grafted recipients given W3/25 + 
cells  from  CY-treated  donors.  However, although  acutely  irradiated  rats  are 
profoundly lymphocytopenic on the day of grafting,  lymphocyte regeneration is 
obvious by  6-7  d  postirradiation  (18),  and  we  therefore  cannot  exclude  the 
possibility that regenerating  host cells may be induced by the adoptively trans- 
ferred  W3/25 + cells  to  mediate  suppression  of the  admixed  normal  W3/25 + 
cells. 
The  findings  we report suggest a  central  role  for the  helper/inducer  T  cell 
subset in both the mediation of rejection and the maintenance of states of specific 
unresponsiveness to allografts. Whether both functions are mediated by the same 
subpopulation, or whether a new population of W3/25 + cells replaces the original 
effector clones remains to be established. Rats with long-surviving grafts are not 
lymphoid  or hemopoietic  cell  chimaeras  (13).  However, the  functioning  graft 
represents a  potential  source of alloantigen  to prime,  induce,  and/or  maintain 
the inhibitory response. Whether this is an essential factor in the maintenance of 
unresponsiveness  remains  to  be  established.  This  form  of  unresponsiveness 
induced in allografted adult animals has obvious potential significance for human 
organ transplantation  if means can be devised whereby it can be induced before 
organ transplantation.  Therefore, further investigation of the requirements for 
its induction are essential. 
Summary 
DA  rats  grafted  with  major  histocompatibility  complex-incompatible  PVG 
heart grafts and treated with cyclosporine (CY) for 10 d do not reject their grafts, 
and  develop a  state  of specific unresponsiveness  toward  PVG allografts.  Cells 
from these animals tested in an adoptive transfer assay were incapable of restoring 
PVG graft rejection, and capable of specifically inhibiting the capacity of adop- 
tively transferred  normal lymph node cells (LNC) to do so. They effected third 
party Wistar/Furth (W/F) graft rejection, however. Adoptive transfer assays with 1692  MEDIATION  OF  ALLOSUPPRESSION  BY  T  HELPER  CELLS 
purified subpopulations of the lymphocytes that mediated this effect showed that 
W3/25 + T  cells of the  helper/inducer subclass,  when  injected alone,  failed to 
restore rejection, and  were also  able,  when  injected  with  normal  LNC  or the 
W/25 + cells separated from them, to prevent these cells from effecting rejection. 
MRC OX8 + T  cells of the cytotoxic/suppressor subclass, B cells, and serum from 
rats with long-surviving grafts all failed to inhibit the allograft responsiveness of 
normal  LNC, and thus were not identified as mediators of the state of specific 
unresponsiveness. 
These results show that the specific unresponsiveness that develops in rats with 
long-surviving grafts,  and  which,  in  part at  least,  is  responsible for prolonged 
graft Survival, is due to an alteration in the alloreactivity of the he/per/inducer 
subclass of T  cells.  These cells not only lack the capacity to initiate a  rejection 
response against the alloantigens of the graft, but also have the ability to inhibit 
the capacity of normal W3/25 + cells to do so. 
Received for publication 23 July 1985. 
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